Data management software company Enlitic is chasing $US100 million in sales from licensing its artificial intelligence technology to healthcare clients, as the company evaluates future funding options that could include an ASX debut.
Founded in 2014 in San Francisco by Aussie AI expert Jeremy Howard, Enlitic was initially designed to use AI to detect anomalies in medical images, helping radiologists triage scans and provide diagnoses.However, the company moved its focus away from clinical AI into data standardisation in 2019, after realising AI-powered diagnostic tools wouldn’t deliver the efficiencies it promised while the medical industry cleaned up the data it feeds into diagnostic algorithms.
The software can tell what part of the anatomy is in the scan, if contrast is present, and if it is the left or right side of the body.